<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Company receives shareholder support to transition toward its nanotechnology and health sciences focus Retains CORE IR for investor relations, public relations, U.S. listing advisory and capital markets advisory GUELPH, ON / ACCESSWIRE / October 4, 2021 / ZEN Graphene Solutions Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that shareholders have approved all resolutions put forward at the annual shareholder meeting held on September 27, 2021.
...read full article on Accesswire
